The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis

The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis

Introduction: Phosphodiesterase type 5 inhibitors (PDE5-Is) are first-line drugs for erectile dysfunction. Non-arteritic anterior ischemic optic neuropathy (NAION) has been linked with PDE5-I use. However, no meta-analysis or conclusive review has explored the association between NAION and PDE5-I us...

Full description

Bibliographic Details
Main Authors: Bing Liu, MD, Linxin Zhu, MM, Jingxiang Zhong, MD, Guohua Zeng, MD, Tuo Deng, MD
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Sexual Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2050116118300357

Similar Items

Similar Items